Answers are grounded in this paper and cite their sources.
Several federal laws have encouraged the development of new drugs by offering longer market exclusivity. The author discusses unintended consequences of these policies and the need for more carefully designed regulations to encourage pharmaceutical innovation.
No takes yet. Share an insight, caveat, or question.
Aaron S. Kesselheim (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: